NEOGENOMICS INC — Director's Dealing 2022

Jul 15, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-07-07

Reporting Person: Kulkarni Shashikant (President of Lab Operations)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	41152	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.15	2029-04-01	Common Stock (88496.0)		Direct

Footnotes

F1: On April 1, 2022, Dr. Kulkarni was granted 88,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.